|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 22 of 47 found articles
| Title: |
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study |
| Author: |
Cremolini, Chiara Loupakis, Fotios Antoniotti, Carlotta Lupi, Cristiana Sensi, Elisa Lonardi, Sara Mezi, Silvia Tomasello, Gianluca Ronzoni, Monica Zaniboni, Alberto Tonini, Giuseppe Carlomagno, Chiara Allegrini, Giacomo Chiara, Silvana D'Amico, Mauro Granetto, Cristina Cazzaniga, Marina Boni, Luca Fontanini, Gabriella Falcone, Alfredo |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 16 (2015) nr. 13 pages 10 p. |
| Year: |
2015 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 22 of 47 found articles
| << previous | next >> |